A Phase Ib Study Administering Rapamycin (Sirolimus) With Ketoconazole in Patients With Advanced Malignancies.

Trial Profile

A Phase Ib Study Administering Rapamycin (Sirolimus) With Ketoconazole in Patients With Advanced Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2012

At a glance

  • Drugs Sirolimus (Primary) ; Ketoconazole
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Feb 2009 Actual patient number (57) reported by ClinicalTrials.gov.
    • 12 Feb 2009 Actual completion date (1 Dec 2008) added from ClinicalTrials.gov.
    • 12 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top